8 Review Questions
Open “Answer” below each question to see the answer and explanation. Think it through yourself first before opening it.
8.1 Basic
Q1
Why do adipocytes appear as “vacuoles” when white adipose tissue is stained with HE? And what should you do to stain and see the fat itself?
Because lipids are dissolved out during the preparation of ordinary paraffin sections, the remains of lipid droplets appear as white empty spaces (Pawlina and Ross 2020). To see the fat itself, stain frozen sections with Oil Red O, which stains neutral lipids red (Mehlem et al. 2013). (Chapter 2)
Q2
Name at least three cell types contained in the “stromal vascular fraction (SVF)” of adipose tissue.
Preadipocytes, vascular endothelial cells, immune cells such as macrophages, etc. (Rosen and Spiegelman 2014). (Chapter 2)
Q3
Choose the one statement about visceral fat (omentum, mesentery) that is incorrect.
- Its veins drain into the portal vein
- It has a denser supply of blood vessels and nerves than subcutaneous fat
- Its preadipocytes have higher proliferative and differentiation capacity than those of subcutaneous fat
- It has more glucocorticoid receptors than subcutaneous fat
3. In cultured human progenitors, abdominal subcutaneous cells accumulate lipid better and proliferate more than omental cells (Tchkonia et al. 2005). Statements 1, 2 and 4 all agree with the summary in Ibrahim (2010). (Chapter 3)
Q4
In the Japanese diagnosis of obesity disease, give the measure used as the criterion for visceral fat accumulation, and its simple surrogate measure.
Visceral fat area of 100 cm² or more on CT at the umbilical level. As a simple surrogate, waist circumference of 85 cm or more for men and 90 cm or more for women (Examination Committee of Criteria for ’Obesity Disease’ in Japan and Japan Society for the Study of Obesity 2002). (Chapter 1)
8.2 Applied
Q5
Explain the “portal hypothesis” using the anatomical features of visceral fat and its lipolytic properties.
Because the veins of visceral fat (mesentery, omentum) drain into the portal vein (Ibrahim 2010), free fatty acids generated by lipolysis there reach the liver directly, before circulating through the body (Björntorp 1990). Since visceral fat is prone to lipolysis and is more insulin-resistant (Ibrahim 2010; Arner 2005), as visceral fat increases, the visceral-derived share of fatty acids reaching the liver rises (from under 10% to about 50%, increasing with visceral fat mass) (Nielsen et al. 2004), which is thought to lead to dyslipidaemia, hyperinsulinaemia and impaired glucose tolerance (Arner 2005). (Chapter 4)
Q6
Which adipokine’s plasma concentration decreases with visceral fat accumulation? Also give two of its main actions.
Adiponectin. In Japanese people it correlates negatively with visceral fat area (Ryo et al. 2004). Actions: improving insulin resistance (mice) (Yamauchi et al. 2001), suppressing monocyte adhesion to vascular endothelium (Ouchi et al. 1999), etc. (Chapter 4)
Q7
Explain, from a hormonal perspective, why visceral fat tends to increase in postmenopausal women.
In a study following premenopausal women for 4 years, subcutaneous fat increased in everyone, but visceral fat increased significantly only in women who transitioned to menopause; in that group, plasma estradiol fell and energy expenditure and fat oxidation also declined (Lovejoy et al. 2008). (Chapter 5)
Q8
A person with 20 kg of body fat and 5×10¹⁰ adipocytes increases their body fat to 40 kg without changing cell number (by hypertrophy alone). By roughly what factor does the mean adipocyte diameter change?
The volume per cell doubles, so the diameter changes by \(2^{1/3} \approx\) 1.26-fold (the geometric relationship between the volume and diameter of a sphere). In the model of Demo 1 in Chapter 7, roughly 94 µm → 118 µm. (Chapters 2 and 7)
8.3 Advanced
Q9
Patients with lipodystrophy develop severe fatty liver and diabetes despite having little body fat. Explain this fact using the “adipose tissue expandability hypothesis.”
In the expandability hypothesis, the key is not obesity itself but the limit of adipose tissue’s expansion capacity; beyond the limit, lipid accumulates in other tissues and causes lipotoxicity (insulin resistance, etc.) (Virtue and Vidal-Puig 2010). In lipodystrophy there is almost no adipose tissue to act as a reservoir, resulting in leptin deficiency, insulin resistance, hypertriglyceridaemia and fatty liver (Oral et al. 2002). This shows that “metabolism also worsens when there is too little adipose tissue.” (Chapter 6)
Q10
Thiazolidinediones (pioglitazone) often increase body weight yet improve insulin resistance. Give the reason from the perspective of fat distribution. Also give one caution when using this drug.
Thiazolidinediones activate PPARγ and promote adipocyte differentiation (Lehmann et al. 1995). In a 16-week pioglitazone study, body weight and fat mass increased, but subcutaneous fat area increased and visceral fat area decreased, and hepatic and peripheral insulin sensitivity improved (Miyazaki et al. 2002). Cautions: fluid retention and worsening of heart failure (Nesto et al. 2003), increased fracture risk (Loke et al. 2009). (Chapter 6)
Q11
Regarding the claim “people who were overweight as children have a higher adipose tissue expansion capacity and are therefore metabolically advantaged as adults,” explain the studies that could support it and the problems with the claim.
Studies that could support it: in obese children, adipocyte number and size increase early from just after age 1, and by age 11 they exceed the mean cell number of non-obese adults (Knittle et al. 1979). Adult cell number is constant and does not decrease with weight loss (Spalding et al. 2008). Also, in adults, the more hyperplastic (“many small cells”) the morphology, the better the insulin sensitivity (Arner et al. 2010).
Problems: no study has been found that directly shows that a history of childhood obesity itself increases adult expansion capacity. Whether a person is hyperplastic or hypertrophic is independent of sex and body weight and is strongly related to the capacity to make new adipocytes in adulthood (Arner et al. 2010). Moreover, the increased cell number does not decrease with weight loss (Spalding et al. 2008). Therefore, one cannot conclude that “having been overweight is advantageous.” (Chapter 6)